Skip to main content
logo
Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
14.21
+0.14 (1.00%)
At close: Aug 11, 2026, 4:00 PM EDT
14.21
0.00 (0.00%)
After-hours: Aug 11, 2026, 4:10 PM EDT

Evommune Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-94.67-68.87-66.81-34.05
Depreciation & Amortization
1.541.391.291
Stock-Based Compensation
12.815.861.721.48
Other Adjustments
-2.64-10.7-1.82-1.75
Changes in Accounts Payable
-2.86-0.846.510.13
Changes in Accrued Expenses
0.482.822.71.19
Changes in Unearned Revenue
--3-3
Changes in Other Operating Activities
3.56-3.1-1.79-0.97
Operating Cash Flow
-74.15-76.44-58.2-29.97
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.5-0.24-0.09-0.12
Purchases of Investments
-325.59-199.17-90.26-91.31
Proceeds from Sale of Investments
125.2284.186.3543
Investing Cash Flow
-200.87-115.31-3.99-48.43

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Issuance of Common Stock
0.73157.290.010.01
Net Common Stock Issued (Repurchased)
0.73157.290.010.01
Issuance of Preferred Stock
-65.2349.8363.98
Net Preferred Stock Issued (Repurchased)
-65.2349.8363.98
Other Financing Activities
116.55-1.76-0.42-0.23
Financing Cash Flow
274.22220.7649.4263.75

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Cash Flow
-0.8129.02-12.77-14.65

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-74.65-76.68-58.28-30.09
Free Cash Flow Growth
----
FCF Margin
-746.54%-589.82%-832.61%-601.76%
Free Cash Flow Per Share
-3.28-12.49-38.64-24.01
Levered Free Cash Flow
-92.46-71.84-59.69-29.83
Unlevered Free Cash Flow
-99.68-84.04-61.39-33.62
SEC Filings: 10-K · 10-Q